Cargando…
Exogenous proline enhances susceptibility of NSCLC to cisplatin via metabolic reprogramming and PLK1-mediated cell cycle arrest
The occurrence of cisplatin resistance is still the main factor limiting the therapeutic effect of non-small cell lung cancer (NSCLC). It is urgent to elucidate the resistance mechanism and develop novel treatment strategies. Targeted metabolomics was first performed to detect amino acids’ content i...
Autores principales: | Han, Bingjie, Sun, Yuanyuan, Zhang, Xiaofen, Yue, Ping, Tian, Meiling, Yan, Dan, Yin, Fanxiang, Qin, Bo, Zhao, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330219/ https://www.ncbi.nlm.nih.gov/pubmed/35910374 http://dx.doi.org/10.3389/fphar.2022.942261 |
Ejemplares similares
-
Identification of solamargine as a cisplatin sensitizer through phenotypical screening in cisplatin-resistant NSCLC organoids
por: Han, Yi, et al.
Publicado: (2022) -
Combination therapy of cisplatin and resveratrol to induce cellular aging in gastric cancer cells: Focusing on oxidative stress, and cell cycle arrest
por: Rahimifard, Mahban, et al.
Publicado: (2023) -
The Novel Small Molecule STK899704 Promotes Senescence of the Human A549 NSCLC Cells by Inducing DNA Damage Responses and Cell Cycle Arrest
por: Park, Chan-Woo, et al.
Publicado: (2018) -
Glucocappasalin Induces G2/M-Phase Arrest, Apoptosis, and Autophagy Pathways by Targeting CDK1 and PLK1 in Cervical Carcinoma Cells
por: Xu, Guangya, et al.
Publicado: (2021) -
Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma
por: Qin, Hanjiao, et al.
Publicado: (2023)